Home/Filings/4/0001209191-22-016376
4//SEC Filing

KEEFE MICHELLE 4

Accession 0001209191-22-016376

CIK 0001610950other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:05 PM ET

Size

10.5 KB

Accession

0001209191-22-016376

Insider Transaction Report

Form 4
Period: 2022-03-02
KEEFE MICHELLE
Pres., Commercial Solutions
Transactions
  • Award

    Class A Common Stock

    2022-03-02+7,84554,156 total
  • Award

    Class A Common Stock

    2022-03-02+2,15858,311 total
  • Award

    Class A Common Stock

    2022-03-02+1,99756,153 total
  • Tax Payment

    Class A Common Stock

    2022-03-02$80.75/sh5,289$427,08753,022 total
Footnotes (4)
  • [F1]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
  • [F2]Includes 84 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
  • [F3]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
  • [F4]Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.

Issuer

Syneos Health, Inc.

CIK 0001610950

Entity typeother

Related Parties

1
  • filerCIK 0001766036

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:05 PM ET
Size
10.5 KB